Phreesia
About: Phreesia Inc is a provider of comprehensive software solutions that improves the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, but not limited to, initial patient contact, registration, appointment scheduling, payments, and post-appointment patient surveys.
Employees: 1,438
0
Funds holding %
of 6,790 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
70% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 20
46% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 48
9% more capital invested
Capital invested by funds: $1.15B [Q2] → $1.25B (+$103M) [Q3]
8% more funds holding
Funds holding: 176 [Q2] → 190 (+14) [Q3]
0.86% more ownership
Funds ownership: 94.5% [Q2] → 95.36% (+0.86%) [Q3]
32% less call options, than puts
Call options by funds: $10.6M | Put options by funds: $15.6M
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$23
9%
upside
Avg. target
$29
37%
upside
High target
$34
61%
upside
4 analyst ratings
3 positive
75%
1 neutral
25%
0 negative
0%
RBC Capital Sean Dodge 36% 1-year accuracy 10 / 28 met price target | 9%upside $23 | Sector Perform Reiterated | 27 Sept 2024 |
JP Morgan Anne Samuel 36% 1-year accuracy 4 / 11 met price target | 33%upside $28 | Overweight Maintained | 9 Sept 2024 |
Truist Securities Jailendra Singh 11% 1-year accuracy 2 / 18 met price target | 47%upside $31 | Buy Maintained | 6 Sept 2024 |
Baird Joseph Vruwink 0% 1-year accuracy 0 / 2 met price target | 61%upside $34 | Outperform Maintained | 6 Sept 2024 |
Financial journalist opinion
Neutral
Business Wire
1 week ago
Phreesia Named to The Software Report's “Top 100 Software Companies” for the Third Consecutive Year
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been selected by The Software Report as one of the “Top 100 Software Companies of 2024” for a third consecutive year.
Positive
Zacks Investment Research
4 weeks ago
Phreesia (PHR) Moves 13.9% Higher: Will This Strength Last?
Phreesia (PHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Neutral
Business Wire
1 month ago
Phreesia Sets Release Date for Fiscal Third Quarter 2025 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it will release its fiscal third quarter 2025 financial results after the close of market trading on Monday, Dec. 9, 2024.
Neutral
Business Wire
1 month ago
Phreesia Achieves Oracle Validated Integration With Oracle Health EHR Expertise for Delivering Proven, Repeatable Integration
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it has achieved Oracle Validated Integration with Oracle Health EHR Expertise for its integration of the Phreesia platform.
Positive
Zacks Investment Research
1 month ago
Down -10.25% in 4 Weeks, Here's Why Phreesia (PHR) Looks Ripe for a Turnaround
Phreesia (PHR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Neutral
Business Wire
1 month ago
Phreesia Joins the Network Advertising Initiative as a Member, Demonstrating Ongoing Commitment to Industry-Leading Privacy Practices
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has joined the NAI to shape the national conversation around data privacy and promote consumer choice and transparency.
Neutral
Business Wire
2 months ago
Phreesia and Ad Council Partnership Yields High Patient Engagement in 3 Mental Health Awareness Campaigns
ALL-REMOTE COMPANY/WILMINGTON, Del. & NEW YORK--(BUSINESS WIRE)--Phreesia has collaborated with the Ad Council to bring three public health campaigns about mental health directly to patients and caregivers.
Neutral
Business Wire
2 months ago
Phreesia Secures New Contract With CMS as Report Shows Gains in Patient Activation in First Year of Kidney Care Choices (KCC) Model
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is pleased to announce that its contract with the CMS Innovation Center for use of the Patient Activation Measure® has been renewed to 2029.
Neutral
Business Wire
2 months ago
CDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary Incontinence
ALL-REMOTE COMPANY/WILMINGTON, Del. & LAFAYETTE, Colo. & SAN FRANCISCO--(BUSINESS WIRE)--The CDC awards grant to Phreesia, NAFC, Health.Equity.Outcomes. and Christina Escobar, MD, at NYU, to combat urinary incontinence in women.
Positive
Seeking Alpha
3 months ago
Phreesia: Remain Bullish Given The Healthy Growth Outlook
I maintain a buy rating for PHR, driven by strong client growth, solid revenue outlook, and increasing transaction sizes in the pipeline. PHR's 2Q25 results show 19% y/y revenue growth and improved profitability, with positive EBITDA and FCF, indicating strong financial health. Despite a slight decline in revenue per AHSC, larger client acquisitions and increased transaction sizes support my 20% growth expectation.
Charts implemented using Lightweight Charts™